Rare Saposin A deficiency: Novel variant and psychosine analysis.
Galactocerebrosidase
Krabbe disease
Newborn screening
PSAP
Psychosine
Journal
Molecular genetics and metabolism
ISSN: 1096-7206
Titre abrégé: Mol Genet Metab
Pays: United States
ID NLM: 9805456
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
11
06
2019
revised:
02
08
2019
accepted:
03
08
2019
pubmed:
24
8
2019
medline:
13
11
2020
entrez:
24
8
2019
Statut:
ppublish
Résumé
Saposin A is a post-translation product of the prosaposin (PSAP) gene that serves as an activator protein of the galactocerebrosidase (GALC) enzyme, and is necessary for the degradation of certain glycosphingolipids. Deficiency of saposin A leads to a clinical picture identical to that of early-infantile Krabbe disease caused by GALC enzyme deficiency. Galactosylsphingosine, also known as psychosine, is a substrate of the GALC enzyme that is known to be elevated in classic Krabbe disease. We present the case of an 18-month-old male with clinical and radiological findings concerning for Krabbe disease who had preserved GALC enzyme activity and negative GALC gene sequencing, but was found to have a homozygous variant, c.257 T > A (p.I86N), in the saposin A peptide of PSAP. Psychosine determination on dried blood spot at 18 months of age was elevated to 12 nmol/L (normal <3 nmol/L). We present this case to add to the literature on the rare diagnosis of atypical Krabbe disease due to saposin A deficiency, to report a novel presumed pathogenic variant within PSAP, and to suggest that individuals with saposin A deficiency may have elevated levels of psychosine, similar to children with classic Krabbe disease due to GALC deficiency.
Identifiants
pubmed: 31439510
pii: S1096-7192(19)30410-X
doi: 10.1016/j.ymgme.2019.08.001
pii:
doi:
Substances chimiques
PSAP protein, human
0
Saposins
0
Psychosine
2238-90-6
Galactosylceramidase
EC 3.2.1.46
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
161-164Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.